Perioperative efficacy and safety of short-course radiotherapy combined with immunochemotherapy in proficient mismatch repair rectal cancer - Quiz - MDSpire

Perioperative efficacy and safety of short-course radiotherapy combined with immunochemotherapy in proficient mismatch repair rectal cancer

  • By

  • Y. Li

  • J. Du

  • M. Zhuang

  • G. Hu

  • W. Qiu

  • X. Wang

  • J. Tang

  • November 15, 2025

  • 0 min

Share

Original Source(s)

Perioperative efficacy and safety of short-course radiotherapy combined with immunochemotherapy in proficient mismatch repair rectal cancer

  • by Y. Li, J. Du, M. Zhuang, G. Hu, W. Qiu, X. Wang, J. Tang

  • November 15, 2025

Related Content

Immune microenvironment evolution across the serrated neoplasia pathway and its relevance to immunotherapy

Ablative stereotactic MR-guided radiotherapy for >10 cm solid pseudopapillary tumor of the pancreas with liver oligometastases: a case report and literature review

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

  • May 12, 2026

  • 7 min